These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 14645308)

  • 1. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
    Crowther CA; Hiller JE; Doyle LW; Haslam RR;
    JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
    Doyle LW; Anderson PJ; Haslam R; Lee KJ; Crowther C;
    JAMA; 2014 Sep; 312(11):1105-13. PubMed ID: 25226476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol.
    Crowther CA; Middleton PF; Wilkinson D; Ashwood P; Haslam R;
    BMC Pregnancy Childbirth; 2013 Apr; 13():91. PubMed ID: 23570677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatal magnesium sulfate and neuroprotection.
    Doyle LW
    Curr Opin Pediatr; 2012 Apr; 24(2):154-9. PubMed ID: 22227787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No. 376-Magnesium Sulphate for Fetal Neuroprotection.
    Magee LA; De Silva DA; Sawchuck D; Synnes A; von Dadelszen P
    J Obstet Gynaecol Can; 2019 Apr; 41(4):505-522. PubMed ID: 30879485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial].
    Marret S; Marpeau L; Follet-Bouhamed C; Cambonie G; Astruc D; Delaporte B; Bruel H; Guillois B; Pinquier D; Zupan-Simunek V; Bénichou J;
    Gynecol Obstet Fertil; 2008 Mar; 36(3):278-88. PubMed ID: 18337147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review.
    Doyle LW; Crowther CA; Middleton P; Marret S
    Obstet Gynecol; 2009 Jun; 113(6):1327-1333. PubMed ID: 19461430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*.
    Marret S; Marpeau L; Zupan-Simunek V; Eurin D; Lévêque C; Hellot MF; Bénichou J;
    BJOG; 2007 Mar; 114(3):310-8. PubMed ID: 17169012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    Doyle LW; Crowther CA; Middleton P; Marret S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004661. PubMed ID: 17636771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal Intravenous Magnesium at 30-34 Weeks' Gestation and Neurodevelopmental Outcomes in Offspring: The MAGENTA Randomized Clinical Trial.
    Crowther CA; Ashwood P; Middleton PF; McPhee A; Tran T; Harding JE;
    JAMA; 2023 Aug; 330(7):603-614. PubMed ID: 37581672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of cerebral palsy using magnesium sulfate in pre-term newborns].
    Marret S; Chollat C; Levèque C; Marpeau L
    Arch Pediatr; 2011 Mar; 18(3):324-30. PubMed ID: 21257296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.
    Crowther CA; Middleton PF; Voysey M; Askie L; Duley L; Pryde PG; Marret S; Doyle LW;
    PLoS Med; 2017 Oct; 14(10):e1002398. PubMed ID: 28976987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
    Magee L; Sawchuck D; Synnes A; von Dadelszen P; ;
    J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal obesity and neuroprotective magnesium sulfate.
    McPherson J; Smiley S; Stamilio D
    Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium sulfate for preterm neuroprotection.
    Ananth CV; Vintzileos AM
    JAMA; 2004 Feb; 291(8):940; author reply 941. PubMed ID: 14982907
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    Doyle LW; Crowther CA; Middleton P; Marret S; Rouse D
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004661. PubMed ID: 19160238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
    Bachnas MA; Mose JC; Effendi JS; Andonotopo W
    J Perinat Med; 2014 Jan; 42(1):129-34. PubMed ID: 24062546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium sulfate for preterm neuroprotection.
    Mittendorf R; Lee KS; Roizen NJ; Pryde PG
    JAMA; 2004 Feb; 291(8):940-1; author reply 941. PubMed ID: 14982906
    [No Abstract]   [Full Text] [Related]  

  • 19. The risks of extending the controversial use of tocolytic magnesium sulfate for the purpose of neuroprotection in preterm labor.
    Mittendorf R; Roizen NJ; Pryde PG
    J Perinatol; 2004 Jul; 24(7):465-6. PubMed ID: 15224123
    [No Abstract]   [Full Text] [Related]  

  • 20. Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomised trial.
    Bain ES; Middleton PF; Yelland LN; Ashwood PJ; Crowther CA
    BJOG; 2014 Apr; 121(5):595-603. PubMed ID: 24387624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.